Elopak ASA

OSE:ELO.OL

26.75 (NOK) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) NOK.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 283.392292.803288.384291.923287.164283.459278.024283.392267.057272.382259.087243.354238.548236.846242.06222.793213.019209.858252.85233.048
Cost of Revenue 174.821184.835178.44181.657187.216175.449174.973182.158173.912184.043169.295169.422160.682154.303154.361138.567130.882129.954164.519151.283
Gross Profit 108.571107.968109.944110.26699.948108.01103.051101.23493.14588.33989.79273.93277.86682.54387.69984.22682.13779.90488.33181.765
Gross Profit Ratio 0.3830.3690.3810.3780.3480.3810.3710.3570.3490.3240.3470.3040.3260.3490.3620.3780.3860.3810.3490.351
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 00000000000000000000
Selling & Marketing Expenses 00000000000000000000
SG&A 0051.41900000000000000000
Other Expenses 89.36281.38232.70900000000000000000
Operating Expenses 89.36281.38283.71282.26176.50877.23677.46776.49969.52174.68673.31988.66972.10365.72472.92567.06868.7658.78465.37667.974
Operating Income 19.20926.58625.81627.84622.25230.37525.49324.65816.10513.65416.473-14.7375.32516.81914.77417.15812.7921.12122.95413.79
Operating Income Ratio 0.0680.0910.090.0950.0770.1070.0920.0870.060.050.064-0.0610.0220.0710.0610.0770.060.1010.0910.059
Total Other Income Expenses Net 1.007-9.39-0.609-1.712-6.941-3.649-0.779-6.529-0.4243.614-3.2512.495-1.214-2.4250.982-1.443-3.964-3.481-3.7550.754
Income Before Tax 20.21617.19625.20726.13415.31126.72624.71418.12915.68117.26914.556-13.8284.11114.415.75615.7158.82617.6419.19914.544
Income Before Tax Ratio 0.0710.0590.0870.090.0530.0940.0890.0640.0590.0630.056-0.0570.0170.0610.0650.0710.0410.0840.0760.062
Income Tax Expense 12.711.6398.5614.2941.8427.3484.3751.9474.4624.0670.9363.524.5513.5083.3494.7654.0933.7125.821-1.244
Net Income 8.37215.16915.86921.50213.58619.47918.52615.4710.943.40513.874-17.348-0.4410.89212.40710.9514.73313.92813.37915.788
Net Income Ratio 0.030.0520.0550.0740.0470.0690.0670.0550.0410.0130.054-0.071-0.0020.0460.0510.0490.0220.0660.0530.068
EPS 0.0310.0560.680.080.590.070.070.060.040.0130.052-0.064-0.0020.040.050.040.0190.060.0530.059
EPS Diluted 0.0310.0560.680.080.590.070.070.060.040.0130.052-0.064-0.0020.040.050.040.0190.060.0530.059
EBITDA 51.48945.35847.18744.04934.3850.49745.69741.26237.535.09332.3816.48213.66531.13232.61131.07818.53835.70936.25127.169
EBITDA Ratio 0.1820.1550.1640.1510.120.1780.1640.1460.140.1290.1250.0680.0570.1310.1350.1390.0870.170.1430.117